Other
Wood smoke
Wood smoke is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_4
1
33%
Ph early_phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Suspended1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed133%
suspended133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
NCT06841913
suspendednot_applicable
Cardiovascular Effects of Exposure to Wood Smoke in Healthy Human Adults
NCT04297761
completedearly_phase_1
Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers
NCT02183753
Clinical Trials (3)
Showing 3 of 3 trials
NCT06841913Phase 4
Woodsmoke Exposure, Influenza Infection, and Nasal Immunity
NCT04297761Not Applicable
Cardiovascular Effects of Exposure to Wood Smoke in Healthy Human Adults
NCT02183753Early Phase 1
Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3